N-acetylcysteine protects against apoptosis through modulation of group i metabotropic glutamate receptor activity

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Sun, Lili ^a   Gu, Li ^a   Wang, Shuting ^a   Yuan, Jifang ^a   Yang, Huimin ^a   Zhu, Jiawei ^a   Zhang, Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 DIHYDROXYPHENYLGLYCINE; ACETYLCYSTEINE; GLUTATHIONE TRANSFERASE; METABOTROPIC RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE; REACTIVE OXYGEN METABOLITE; ROTENONE; STAUROSPORINE; 3,4 DIHYDROXYPHENYLETHYLENE GLYCOL; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; DRUG DERIVATIVE; ENZYME INHIBITOR; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR; SCAVENGER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLIA CELL; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; ANIMAL; CELL LINE; CELL SURVIVAL; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT;

RATTUS;

ACETYLCYSTEINE; ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FREE RADICAL SCAVENGERS; METHOXYHYDROXYPHENYLGLYCOL; OXIDATION-REDUCTION; PARKINSON DISEASE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, METABOTROPIC GLUTAMATE; STAUROSPORINE;

EID: 84863348583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032503     Document Type: Article

References (32)

1. Maiese K, Chong ZZ, Li F, (2005) Driving cellular plasticity and survival through the signal transduction pathways of metabotropic glutamate receptors. Curr Neurovasc Res 2: 425-446.
2. Pshenichkin S, Dolinska M, Klauzinska M, Luchenko V, Grajkowska E, et al. (2008) Dual neurotoxic and neuroprotective role of metabotropic glutamate receptor 1 in conditions of trophic deprivation-possible role as a dependence receptor. Neuropharmacology 55: 500-508.
3. Allen JW, Knoblach SM, Faden AI, (2000) Activation of group I metabotropic glutamate receptors reduces neuronal apoptosis but increases necrotic cell death in vitro. Cell Death Differ 7: 470-476.
4. Deng W, Wang H, Rosenberg PA, Volpe JJ, Jensen FE, (2004) Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proc Natl Acad Sci U S A 101: 7751-7756.
5. Berkeley JL, Levey AI, (2003) Cell-specific extracellular signal-regulated kinase activation by multiple G protein-coupled receptor families in hippocampus. Mol Pharmacol 63: 128-135.
6. Thandi S, Blank JL, Challiss RA, (2002) Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways. J Neurochem 83: 1139-1153.
7. Alonso M, Medina JH, Pozzo-Miller L, (2004) ERK1/2 activation is necessary for BDNF to increase dendritic spine density in hippocampal CA1 pyramidal neurons. Learn Mem 11: 172-178.
8. Brunzell DH, Russell DS, Picciotto MR, (2003) In vivo nicotine treatment regulates mesocorticolimbic CREB and ERK signaling in C57Bl/6J mice. J Neurochem 84: 1431-1441.
9. Lin E, Cavanaugh JE, Leak RK, Perez RG, Zigmond MJ, (2008) Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells. J Neurosci Res 86: 108-117.
10. Bi J, Jiang B, Hao S, Zhang A, Dong Y, et al. (2009) Catalpol attenuates nitric oxide increase via ERK signaling pathways induced by rotenone in mesencephalic neurons. Neurochem Int 54: 264-270.
11. Kulich SM, Chu CT, (2001) Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease. J Neurochem 77: 1058-1066.
12. Oh-hashi K, Maruyama W, Yi H, Takahashi T, Naoi M, et al. (1999) Mitogen-activated protein kinase pathway mediates peroxynitrite- induced apoptosis in human dopaminergic neuroblastoma SH-SY5Y cells. Biochem Biophys Res Commun 263: 504-509.
13. Meli E, Baronti R, Pangallo M, Picca R, Moroni F, et al. (2005) Group I metabotropic glutamate receptors stimulate the activity of poly(ADP-ribose) polymerase in mammalian mGlu1-transfected cells and in cortical cell cultures. Neuropharmacology 49: 80-88.
14. Sagara Y, Schubert D, (1998) The activation of metabotropic glutamate receptors protects nerve cells from oxidative stress. J Neurosci 18: 6662-6671.
15. Albasanz JL, Ros M, Martin M, (1997) Characterization of metabotropic glutamate receptors in rat C6 glioma cells. Eur J Pharmacol 326: 85-91.
16. Choe ES, Wang JQ, (2001) Group I metabotropic glutamate receptors control phosphorylation of CREB, Elk-1 and ERK via a CaMKII-dependent pathway in rat striatum. Neurosci Lett 313: 129-132.
17. Gallagher SM, Daly CA, Bear MF, Huber KM, (2004) Extracellular signal-regulated protein kinase activation is required for metabotropic glutamate receptor-dependent long-term depression in hippocampal area CA1. J Neurosci 24: 4859-4864.
18. Posadas I, Vellecco V, Santos P, Prieto-Lloret J, Cena V, (2007) Acetaminophen potentiates staurosporine-induced death in a human neuroblastoma cell line. Br J Pharmacol 150: 577-585.
19. Zhang XD, Gillespie SK, Hersey P, (2004) Staurosporine induces apoptosis of melanoma by both caspase-dependent and-independent apoptotic pathways. Mol Cancer Ther 3: 187-197.
20. Agari T, Yasuhara T, Matsui T, Kuramoto S, Kondo A, et al. (2008) Intrapallidal metabotropic glutamate receptor activation in a rat model of Parkinson's disease: behavioral and histological analyses. Brain Res 1203: 189-196.
21. Battaglia G, Busceti CL, Molinaro G, Biagioni F, Storto M, et al. (2004) Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine in mice. J Neurosci 24: 828-835.
22. Dauer W, Przedborski S, (2003) Parkinson's Disease: Mechanisms and Models. Neuron 39: 889-909.
23. John WH, Natalie GA, Melanie HC, Edwin GK, (1992) ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ. Proc. Nati. Acad. Sci 89: 2365-2369.
24. Zhou F, Wu JY, Sun XL, Yao HH, Ding JH, et al. (2007) Iptakalim alleviates Rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia- mediated neuroinflammation. Neuropsychopharmacol 32: 2570-2580.
25. Monti B, Gatta V, Piretti F, Raffaelli SS, Virgili M, et al. (2010) Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein. Neurotox Res 17: 130-141.
26. Martin V, Herrera F, Garcia-Santos G, Antolin I, Rodriguez-Blanco J, et al. (2007) Signaling pathways involved in antioxidant control of glioma cell proliferation. Free Radic Biol Med 42: 1715-22.
27. Bonsi P, Cuomo D, Picconi B, Sciamanna G, Tscherter A, et al. (2007) Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson's disease. Amino Acids 32: 189-195.
28. Dekundy A, Pietraszek M, Schaefer D, Cenci MA, Danysz W, (2006) Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease. Brain Res Bull 69: 318-326.
29. Morin N, Gregoire L, Gomez-Mancilla B, Gasparini F, Di Paolo T, (2010) Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. Neuropharmacology 58: 981-986.
30. Park SW, Kim SH, Park KH, Kim SD, Kim JY, et al. (2004) Preventive effect of antioxidants in MPTP-induced mouse model of Parkinson's disease. Neurosci Lett 363: 243-246.
31. Maiese K, Vincent AM, (1999) Group I metabotropic receptors down-regulate nitric oxide induced caspase-3 activity in rat hippocampal neurons. Neurosci Lett 264: 17-20.
32. Szydlowska K, Kaminska B, Baude A, Parsons CG, Danysz W, (2007) Neuroprotective activity of selective mGlu1 and mGlu5 antagonists in vitro and in vivo. Eur J Pharmacol 554: 18-29.